{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:55:41Z","timestamp":1789480541726,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10073-z","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:25:24Z","timestamp":1754339124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["FTO-mediated the destabilization of RASGRF1 mRNA impedes thyroid cancer progression and suppresses macrophage M2 polarization"],"prefix":"10.1007","volume":"41","author":[{"given":"Zongyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangshi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"10073_CR1","doi-asserted-by":"publisher","unstructured":"Allegri L, Baldan F, Molteni E, Mio C, Damante G. Role of m6A RNA Methylation in thyroid cancer cell lines. Int J Mol Sci. 2022;23(19):11516. https:\/\/doi.org\/10.3390\/ijms231911516.","DOI":"10.3390\/ijms231911516"},{"issue":"1","key":"10073_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14. https:\/\/doi.org\/10.1186\/s12943-022-01500-4.","journal-title":"Mol Cancer"},{"issue":"1","key":"10073_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1):455. https:\/\/doi.org\/10.1038\/s41392-023-01705-z.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10073_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: A Review. JAMA. 2024;331(5):425\u201335. https:\/\/doi.org\/10.1001\/jama.2023.26348.","journal-title":"JAMA"},{"key":"10073_CR5","doi-asserted-by":"publisher","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021;22(13):6995. https:\/\/doi.org\/10.3390\/ijms22136995.","DOI":"10.3390\/ijms22136995"},{"issue":"10387","key":"10073_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/s0140-6736(23)00020-x","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401(10387):1531\u201344. https:\/\/doi.org\/10.1016\/s0140-6736(23)00020-x.","journal-title":"Lancet"},{"key":"10073_CR7","doi-asserted-by":"publisher","unstructured":"Cooper AJ, Kobayashi Y, Kim D, Clifford SE, Kravets S, Dahlberg SE, et al. Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an exceptional responder to sunitinib with non-small cell lung cancer. Clin Cancer Res. 2020;26(15):4072\u20134079. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0397.","DOI":"10.1158\/1078-0432.CCR-20-0397"},{"issue":"11","key":"10073_CR8","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.drudis.2021.06.004","volume":"26","author":"S Garbo","year":"2021","unstructured":"Garbo S, Zwergel C, Battistelli C. m6A RNA methylation and beyond - The epigenetic machinery and potential treatment options. Drug Discov Today. 2021;26(11):2559\u201374. https:\/\/doi.org\/10.1016\/j.drudis.2021.06.004.","journal-title":"Drug Discov Today"},{"issue":"5","key":"10073_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/cbdd.14330","volume":"102","author":"S Ge","year":"2023","unstructured":"Ge S, Sun X, Sang L, Zhang M, Yan X, Ju Q, et al. Curcumin inhibits malignant behavior of colorectal cancer cells by regulating M2 polarization of tumor-associated macrophages and metastasis associated in colon cancer 1 (MACC1) expression. Chem Biol Drug des. 2023;102(5):1202\u201312. https:\/\/doi.org\/10.1111\/cbdd.14330.","journal-title":"Chem Biol Drug des"},{"issue":"5","key":"10073_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/pas.0000000000001839","volume":"46","author":"K Goto","year":"2022","unstructured":"Goto K, Pissaloux D, Fraitag S, Amini M, Vaucher R, Tirode F, et al. RASGRF1-rearranged Cutaneous Melanocytic Neoplasms With Spitzoid Cytomorphology: A Clinicopathologic and Genetic Study of 3 Cases. Am J Surg Pathol. 2022;46(5):655\u201363. https:\/\/doi.org\/10.1097\/pas.0000000000001839.","journal-title":"Am J Surg Pathol"},{"key":"10073_CR11","doi-asserted-by":"publisher","first-page":"109553","DOI":"10.1016\/j.cellsig.2020.109553","volume":"69","author":"X Gu","year":"2020","unstructured":"Gu X, Zhang Y, Li D, Cai H, Cai L, Xu Q. N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation. Cell Signal. 2020;69:109553. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109553.","journal-title":"Cell Signal"},{"key":"10073_CR12","doi-asserted-by":"publisher","unstructured":"Hao Q, Chen J, Lu H, Zhou X. The ARTS of p53-dependent mitochondrial apoptosis. J Mol Cell Biol. 2023;14(10):mjac074. https:\/\/doi.org\/10.1093\/jmcb\/mjac074.","DOI":"10.1093\/jmcb\/mjac074"},{"key":"10073_CR13","doi-asserted-by":"publisher","unstructured":"Hsu JB, Lee TY, Cheng SJ, Lee GA, Chen YC, Le NQK, et al. Identification of Differentially Expressed Genes in Different Glioblastoma Regions and Their Association with Cancer Stem Cell Development and Temozolomide Response. J Pers Med. 2021;11(11). https:\/\/doi.org\/10.3390\/jpm11111047.","DOI":"10.3390\/jpm11111047."},{"key":"10073_CR14","doi-asserted-by":"publisher","unstructured":"Hu R, Shi Z, Yang J, Ren Y, Li X. Anti-Ferroptosis: A Promising Therapeutic Method for Thyroid Cancer. Front Biosci (Landmark Ed). 2024;29(2): 77. https:\/\/doi.org\/10.31083\/j.fbl2902077.","DOI":"10.31083\/j.fbl2902077."},{"issue":"4","key":"10073_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang Y, Su R, Sheng Y, Dong L, Dong Z, Xu H, et al. Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia. Cancer Cell. 2019;35(4):677-91.e10. https:\/\/doi.org\/10.1016\/j.ccell.2019.03.006.","journal-title":"Cancer Cell"},{"issue":"8","key":"10073_CR16","doi-asserted-by":"publisher","first-page":"e23115","DOI":"10.1002\/jbt.23115","volume":"36","author":"D Huang","year":"2022","unstructured":"Huang D, Qiu H, Miao L, Guo L, Zhang X, Lin M, et al. Cdc42 promotes thyroid cancer cell proliferation and migration and tumor-associated macrophage polarization through the PTEN\/AKT pathway. J Biochem Mol Toxicol. 2022;36(8):e23115. https:\/\/doi.org\/10.1002\/jbt.23115.","journal-title":"J Biochem Mol Toxicol"},{"issue":"14","key":"10073_CR17","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1158\/1078-0432.ccr-21-4291","volume":"28","author":"L Hunihan","year":"2022","unstructured":"Hunihan L, Zhao D, Lazowski H, Li M, Qian Y, Abriola L, et al. RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition. Clin Cancer Res. 2022;28(14):3091\u2013103. https:\/\/doi.org\/10.1158\/1078-0432.ccr-21-4291.","journal-title":"Clin Cancer Res"},{"key":"10073_CR18","doi-asserted-by":"publisher","first-page":"857765","DOI":"10.3389\/fendo.2022.857765","volume":"13","author":"FH Ji","year":"2022","unstructured":"Ji FH, Fu XH, Li GQ, He Q, Qiu XG. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner. Front Endocrinol (Lausanne). 2022;13:857765. https:\/\/doi.org\/10.3389\/fendo.2022.857765.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10073_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12094-022-02940-6","volume":"25","author":"FH Ji","year":"2023","unstructured":"Ji FH, Yang Z, Sun C, Lowe S, Qiu XG. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer. Clin Transl Oncol. 2023;25(1):269\u201382. https:\/\/doi.org\/10.1007\/s12094-022-02940-6.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10073_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10073_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12033-020-00269-5","volume":"62","author":"R Karthiya","year":"2020","unstructured":"Karthiya R, Khandelia P. m6A RNA Methylation: Ramifications for Gene Expression and Human Health. Mol Biotechnol. 2020;62(10):467\u201384. https:\/\/doi.org\/10.1007\/s12033-020-00269-5.","journal-title":"Mol Biotechnol"},{"issue":"5","key":"10073_CR22","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.esmoop.2021.100253","volume":"6","author":"M Kirchner","year":"2021","unstructured":"Kirchner M, Kluck K, Brandt R, Volckmar AL, Penzel R, Kazdal D, et al. The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma. ESMO Open. 2021;6(5):100253. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100253.","journal-title":"ESMO Open"},{"key":"10073_CR23","doi-asserted-by":"publisher","first-page":"115323","DOI":"10.1016\/j.ecoenv.2023.115323","volume":"262","author":"WY Lee","year":"2023","unstructured":"Lee WY, Park HJ. T-2 mycotoxin Induces male germ cell apoptosis by ROS-mediated JNK\/p38 MAPK pathway. Ecotoxicol Environ Saf. 2023;262:115323. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.115323.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"10073_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.devcel.2023.01.006","volume":"58","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Shin KJ, Jang HJ, Ryu JS, Lee CY, Yoon JH, et al. GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis. Dev Cell. 2023;58(4):320-34.e8. https:\/\/doi.org\/10.1016\/j.devcel.2023.01.006.","journal-title":"Dev Cell"},{"issue":"7","key":"10073_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.neo.2021.05.006","volume":"23","author":"B Li","year":"2021","unstructured":"Li B, Huang Z, Yu W, Liu S, Zhang J, Wang Q, et al. Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma. Neoplasia. 2021;23(7):704\u201317. https:\/\/doi.org\/10.1016\/j.neo.2021.05.006.","journal-title":"Neoplasia"},{"issue":"7","key":"10073_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.trecan.2022.02.010","volume":"8","author":"Y Li","year":"2022","unstructured":"Li Y, Su R, Deng X, Chen Y, Chen J. FTO in cancer: functions, molecular mechanisms, and therapeutic implications. Trends Cancer. 2022;8(7):598\u2013614. https:\/\/doi.org\/10.1016\/j.trecan.2022.02.010.","journal-title":"Trends Cancer"},{"issue":"1","key":"10073_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12864-021-07895-6","volume":"22","author":"R Lin","year":"2021","unstructured":"Lin R, Fogarty CE, Ma B, Li H, Ni G, Liu X, et al. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. BMC Genomics. 2021;22(1):576. https:\/\/doi.org\/10.1186\/s12864-021-07895-6.","journal-title":"BMC Genomics"},{"issue":"2","key":"10073_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ymthe.2022.10.012","volume":"31","author":"Z Lin","year":"2023","unstructured":"Lin Z, Wan AH, Sun L, Liang H, Niu Y, Deng Y, et al. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Mol Ther. 2023;31(2):517\u201334. https:\/\/doi.org\/10.1016\/j.ymthe.2022.10.012.","journal-title":"Mol Ther"},{"issue":"5","key":"10073_CR29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","volume":"29","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W. p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ. 2022;29(5):895\u2013910. https:\/\/doi.org\/10.1038\/s41418-022-00943-y.","journal-title":"Cell Death Differ"},{"issue":"2","key":"10073_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ecl.2021.11.020","volume":"51","author":"A Maniakas","year":"2022","unstructured":"Maniakas A, Zafereo M, Cabanillas ME. Anaplastic Thyroid Cancer: New Horizons and Challenges. Endocrinol Metab Clin North Am. 2022;51(2):391\u2013401. https:\/\/doi.org\/10.1016\/j.ecl.2021.11.020.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10073_CR31","doi-asserted-by":"publisher","unstructured":"Manzella L, Stella S, Pennisi MS, Tirr\u00f2 E, Massimino M, Romano C, et al. New insights in thyroid cancer and p53 family proteins. Int J Mol Sci. 2017;18(6):1325. https:\/\/doi.org\/10.3390\/ijms18061325.","DOI":"10.3390\/ijms18061325"},{"issue":"5","key":"10073_CR32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ijc.33690","volume":"149","author":"F Nabhan","year":"2021","unstructured":"Nabhan F, Dedhia PH, Ringel MD. Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer. 2021;149(5):984\u201392. https:\/\/doi.org\/10.1002\/ijc.33690.","journal-title":"Int J Cancer"},{"issue":"10","key":"10073_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41419-022-05317-3","volume":"13","author":"B Ou","year":"2022","unstructured":"Ou B, Liu Y, Gao Z, Xu J, Yan Y, Li Y, et al. Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation. Cell Death Dis. 2022;13(10):905. https:\/\/doi.org\/10.1038\/s41419-022-05317-3.","journal-title":"Cell Death Dis"},{"key":"10073_CR34","doi-asserted-by":"publisher","unstructured":"Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M. Update on Fundamental Mechanisms of Thyroid Cancer. Front Endocrinol (Lausanne). 2020;11: 102. https:\/\/doi.org\/10.3389\/fendo.2020.00102.","DOI":"10.3389\/fendo.2020.00102."},{"issue":"Pt 3","key":"10073_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2022.05.009","volume":"86","author":"D Ramesh-Kumar","year":"2022","unstructured":"Ramesh-Kumar D, Guil S. The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer. Semin Cancer Biol. 2022;86(Pt 3):18\u201331. https:\/\/doi.org\/10.1016\/j.semcancer.2022.05.009.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10073_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.biotechadv.2011.05.011","volume":"30","author":"E Sacco","year":"2012","unstructured":"Sacco E, Metalli D, Spinelli M, Manzoni R, Samalikova M, Grandori R, et al. Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells. Biotechnol Adv. 2012;30(1):233\u201343. https:\/\/doi.org\/10.1016\/j.biotechadv.2011.05.011.","journal-title":"Biotechnol Adv"},{"issue":"3","key":"10073_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","volume":"83","author":"E Sendinc","year":"2023","unstructured":"Sendinc E, Shi Y. RNA m6A methylation across the transcriptome. Mol Cell. 2023;83(3):428\u201341. https:\/\/doi.org\/10.1016\/j.molcel.2023.01.006.","journal-title":"Mol Cell"},{"issue":"1","key":"10073_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, et al. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. Cancer Cell. 2020;38(1):79-96.e11. https:\/\/doi.org\/10.1016\/j.ccell.2020.04.017.","journal-title":"Cancer Cell"},{"key":"10073_CR39","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2020.5956","author":"R Tian","year":"2020","unstructured":"Tian R, Zhang S, Sun D, Bei C, Li D, Zheng C, et al. M6A Demethylase FTO Plays a Tumor Suppressor Role in Thyroid Cancer. DNA Cell Biol. 2020. https:\/\/doi.org\/10.1089\/dna.2020.5956.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"10073_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13058-016-0788-z","volume":"18","author":"N Uehiro","year":"2016","unstructured":"Uehiro N, Sato F, Pu F, Tanaka S, Kawashima M, Kawaguchi K, et al. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer. Breast Cancer Res. 2016;18(1):129. https:\/\/doi.org\/10.1186\/s13058-016-0788-z.","journal-title":"Breast Cancer Res"},{"issue":"6","key":"10073_CR41","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y, et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol. 2023;97(6):1439\u201351. https:\/\/doi.org\/10.1007\/s00204-023-03476-6.","journal-title":"Arch Toxicol"},{"issue":"12","key":"10073_CR42","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1002\/ijc.32961","volume":"146","author":"B Wu","year":"2020","unstructured":"Wu B, Lu X, Shen H, Yuan X, Wang X, Yin N, et al. Intratumoral heterogeneity and genetic characteristics of prostate cancer. Int J Cancer. 2020;146(12):3369\u201378. https:\/\/doi.org\/10.1002\/ijc.32961.","journal-title":"Int J Cancer"},{"issue":"6","key":"10073_CR43","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616\u201324. https:\/\/doi.org\/10.1038\/s41422-018-0040-8.","journal-title":"Cell Res"},{"issue":"6","key":"10073_CR44","doi-asserted-by":"publisher","first-page":"R319","DOI":"10.1530\/erc-19-0098","volume":"26","author":"MA Zaballos","year":"2019","unstructured":"Zaballos MA, Acu\u00f1a-Ruiz A, Morante M, Crespo P, Santisteban P. Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer. Endocr Relat Cancer. 2019;26(6):R319\u201344. https:\/\/doi.org\/10.1530\/erc-19-0098.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10073_CR45","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s12094-020-02516-2","volume":"23","author":"C Zhang","year":"2021","unstructured":"Zhang C, Gu X, Pan M, Yuan Q, Cheng H. Senescent thyroid tumor cells promote their migration by inducing the polarization of M2-like macrophages. Clin Transl Oncol. 2021;23(6):1253\u201361. https:\/\/doi.org\/10.1007\/s12094-020-02516-2.","journal-title":"Clin Transl Oncol"},{"issue":"22","key":"10073_CR46","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1158\/0008-5472.can-22-1475","volume":"82","author":"LY Zhu","year":"2022","unstructured":"Zhu LY, Yuan JB, Zhang L, He CX, Lin X, Xu B, et al. Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis. Cancer Res. 2022;82(22):4153\u201363. https:\/\/doi.org\/10.1158\/0008-5472.can-22-1475.","journal-title":"Cancer Res"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10073-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T19:04:00Z","timestamp":1754420640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10073-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10073"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10073-z","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of the Second Affiliated Hospital of Xi\u2019an Jiaotong University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal\u00a0studies\u00a0were\u00a0performed\u00a0in\u00a0compliance\u00a0with\u00a0the\u00a0ARRIVE\u00a0guidelines\u00a0and\u00a0the\u00a0Basel\u00a0Declaration.\u00a0All\u00a0animals\u00a0received\u00a0humane\u00a0care\u00a0according\u00a0to\u00a0the\u00a0National\u00a0Institutes\u00a0of\u00a0Health\u00a0(USA)\u00a0guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}],"article-number":"123"}}